Small molecule inhibitors of Lck SH2 domain binding
US8476273B2 · kind B2 · utility
0Cited by
0References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 18, 2008 |
| Grant date | Jul 2, 2013 |
| Priority date | — |
| Expiry date | Mar 21, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides materials and methods for modulating an immune response. The materials and methods may be used to treat diseases associated with an aberrant immune response. In some embodiments, materials and methods of the invention may be used to treat autoimmune diseases, for example, rheumatoid arthritis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.